{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:18:59Z","timestamp":1775146739667,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Major Scientific and Technological Special Project of China","award":["2018ZX09711003-006"],"award-info":[{"award-number":["2018ZX09711003-006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The objective of the present study was to define whether inhaled tetrandrine (TET) could be a promising way to achieve the local effect on its therapeutic efficacy based on biodistribution features using the LPS-treated acute lung injury (ALI) model. The tissue distribution profiles of inhaled TET in normal and ALI mouse models showed that pulmonary inflammation led to an altered distribution in a tissue-specific way. More TET accumulated in almost all tissues including in the blood. Among them, the increased exposure in the lungs was significantly higher than in the other tissues. However, there was a negative increase in the brain. In vitro turnover rates of TET in mouse liver microsomes (MLM) from normal and LPS-treated mice showed significant differences. In the presence of NADPH, TET demonstrated relatively low hepatic clearance (89 mL\/h\/kg) in that of normal MLM (140 mL\/h\/kg). Intracellular uptakes of TET in A549, HepG2, RAW264.7, and C8-D1A cells were significantly inhibited by monensin, indicating that the intracellular accumulation of TET is driven by lysosomal trapping. However, in the presence of LPS, only the lysosomal pH partitioning of TET in A549 cell lines increased (~30%). Bidirectional transport of TET across LLC-PK1 cell expressing MDR1 showed that MDR1 is responsible for the low brain exposure via effluxion (ER = 32.46). From the observed overall agreement between the in vitro and in vivo results, we concluded that the downregulation of the CYP3A together with strengthened pulmometry lysosomal trapping magnified the retention of inhaled TET in the lung. These results therefore open the possibility of prolonging the duration of the local anti-inflammation effect against respiratory disorders.<\/jats:p>","DOI":"10.3390\/ijms232112948","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:17:48Z","timestamp":1666768668000},"page":"12948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Alternation of Organ-Specific Exposure in LPS-Induced Pneumonia Mice after the Inhalation of Tetrandrine Is Governed by Metabolizing Enzyme Suppression and Lysosomal Trapping"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8085-0504","authenticated-orcid":false,"given":"Furun","family":"Wang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengxu","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Fu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Yao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingchao","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Lv","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenpeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rigao","family":"Ding","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Zhuang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"ref_1","first-page":"1107","article-title":"Pharmacological actions of tetrandrine in inflammatory pulmonary diseases","volume":"23","author":"Xie","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_2","first-page":"205","article-title":"Strategies for the treatment of pneumoconiosis","volume":"8","author":"Banks","year":"1993","journal-title":"Occup. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11101-020-09673-w","article-title":"A critical review: Traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji)","volume":"19","author":"Jiang","year":"2020","journal-title":"Phytochem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jphp.13339","article-title":"Tetrandrine: A review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems","volume":"72","author":"Luan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Song, J.W., Liu, Y.S., Guo, Y.R., Zhong, W.X., Guo, Y.P., and Guo, L. (2022). Nano-Liposomes Double Loaded with Curcumin and Tetrandrine: Preparation, Characterization, Hepatotoxicity and Anti-Tumor Effects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126858"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00653","DOI":"10.1002\/prp2.653","article-title":"Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19","volume":"8","author":"Heister","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102212","DOI":"10.1016\/j.ceca.2020.102212","article-title":"Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?","volume":"88","author":"Grimm","year":"2020","journal-title":"Cell Calcium."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/acs.molpharmaceut.0c00026","article-title":"Inhalation of Tetrandrine-hydroxypropyl-beta-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment","volume":"17","author":"Su","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Plaunt, A.J., Islam, S., Macaluso, T., Gauani, H., Baker, T., Chun, D., Viramontes, V., Chang, C., Corboz, M.R., and Chapman, R.W. (2021). Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020548"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12951-021-00803-w","article-title":"Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Morgan, E.T. (2017). Regulation of Drug-Metabolizing Enzymes and Drug Metabolism by Inflammatory Responses. Drug Metabolism in Diseases, Academic Press.","DOI":"10.1016\/B978-0-12-802949-7.00002-X"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Saib, S., and Delavenne, X. (2021). Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13101544"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17425255.2017.1311323","article-title":"Inflammation and pharmacokinetics: Potential implications for HIV-infection","volume":"13","author":"Seifert","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1872312811666170301110349","article-title":"Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics","volume":"11","author":"Norgard","year":"2017","journal-title":"Drug Metab. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1389200221999210101232057","article-title":"Malaria-induced Alterations of Drug Kinetics and Metabolism in Rodents and Humans","volume":"22","author":"Paumgartten","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"ref_19","first-page":"37","article-title":"The Pro-Inflammatory Cytokine Cascade","volume":"31","author":"Cavaillon","year":"2002","journal-title":"Update Intensive Care Emerg. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"De-Oliveira, A.C., Po\u00e7a, K.S., Totino, P.R., and Paumgartten, F.J. (2015). Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: Low-dose effects and non-monotonic dose-response relationship. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117842"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.120.090704","article-title":"The Impact of Infection and Inflammation on Drug Metabolism, Active Transport, and Systemic Drug Concentrations in Veterinary Species","volume":"48","author":"Martinez","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: Delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2017.11.013","article-title":"Pulmonary absorption-estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis","volume":"124","author":"Eriksson","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals","volume":"44","author":"Downey","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0773.1995.tb01050.x","article-title":"The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues","volume":"77","author":"Daniel","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/dmd.118.084541","article-title":"Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-\/Lysosomal System in Rat Hepatocytes","volume":"47","author":"Schmitt","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106518","DOI":"10.1016\/j.rmed.2021.106518","article-title":"Large underreporting of COPD as cause of death-results from a population-based cohort study","volume":"186","author":"Lindberg","year":"2021","journal-title":"Respir. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","article-title":"Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Wang","year":"2017","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.apsb.2021.04.023","article-title":"Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design","volume":"11","author":"Qiao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.apsb.2021.08.009","article-title":"Pulmonary delivery of siRNA against acute lung injury\/acute respiratory distress syndrome","volume":"12","author":"Zoulikha","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-8741(99)00141-5","article-title":"Anti-inflammatory effects of fangchinoline and tetrandrine","volume":"69","author":"Choi","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00180-8","article-title":"Initial responses to endotoxins and Gram-negative bacteria","volume":"323","author":"Heumann","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ndolo, R.A., Luan, Y., Duan, S., Forrest, M.L., and Krise, J.P. (2012). Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049366"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jfda.2018.11.005","article-title":"The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders","volume":"27","author":"Wu","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"ref_36","first-page":"742149","article-title":"Structure and antimicrobial properties of monensin A and its derivatives: Summary of the achievements","volume":"2013","author":"Aowicki","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/mol.105.017954","article-title":"Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide","volume":"69","author":"Hartz","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.106.029512","article-title":"Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier","volume":"71","author":"Bauer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1083\/jcb.61.1.188","article-title":"Analytical study of microsomes and isolated subcellular membranes from rat liver. II. Preparation and composition of the microsomal fraction","volume":"61","author":"Beaufay","year":"1974","journal-title":"J. Cell Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:14Z","timestamp":1760144594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":39,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232112948"],"URL":"https:\/\/doi.org\/10.3390\/ijms232112948","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}